Klebsiella pneumoniae Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 100 pages | ID: KF4773F0EFF9EN
VPAResearch

Abstracts

Klebsiella pneumoniae Infections Drug pipeline report- 2020 is an annual R&D review of Klebsiella pneumoniae Infections pipeline candidates. The report presents the current status of all major Klebsiella pneumoniae Infections therapeutic compounds. Detailed insights into Klebsiella pneumoniae Infections pipeline development, current status, companies, drug profiles and Klebsiella pneumoniae Infections preclinical and clinical trials are included.

2020 Klebsiella pneumoniae Infections Pipeline Market Insights
Klebsiella pneumoniae Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Klebsiella pneumoniae Infections therapies, pipeline by phase and others are included.

Klebsiella pneumoniae Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Klebsiella pneumoniae Infections Therapeutic Drug candidates
Both active and inactive Klebsiella pneumoniae Infections pipeline drug candidates are included in the report

Klebsiella pneumoniae Infections Clinical Trials and preclinical Studies
Klebsiella pneumoniae Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Klebsiella pneumoniae Infections pipeline market developments
Klebsiella pneumoniae Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Klebsiella pneumoniae Infections pipeline companies in active development
The report analyzes Klebsiella pneumoniae Infections pipeline of the below companies-

ABAC Therapeutics SA, Abgentis Ltd, AmpliPhi Biosciences Corp, Appili Therapeutics Inc, Armata Pharmaceuticals Inc, Biomx Ltd, C3J Therapeutics Inc, ContraFect Corp, Daiichi Sankyo Co Ltd, Debiopharm International SA, EnBiotix Inc, Evaxion Biotech ApS, F. Hoffmann-La Roche Ltd, Fedora Pharmaceuticals Inc, Forge Therapeutics Inc, Kyorin Pharmaceutical Co Ltd, LegoChem Biosciences Inc, Melinta Therapeutics Inc, Microbiotix Inc, Neoculi Pty Ltd, Nosopharm SAS, Oryn Therapeutics, Phico Therapeutics Ltd, Shionogi & Co Ltd, Soligenix Inc, Spero Therapeutics Inc, Syntiron LLC, Tetraphase Pharmaceuticals Inc, Vaxdyn SL, Vaxxilon AG, X4 Pharmaceuticals

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
31 Companies investing in Klebsiella pneumoniae Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Klebsiella pneumoniae Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Klebsiella pneumoniae Infections Disease Overview
1.2 Klebsiella pneumoniae Infections Drug Pipeline Snapshot, 2020
  1.2.1 Klebsiella pneumoniae Infections Pipeline Drugs by Phase
  1.2.2 Klebsiella pneumoniae Infections Pipeline Drugs by Company
  1.2.3 Klebsiella pneumoniae Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Klebsiella pneumoniae Infections Pipeline Drugs by Route of Administration

2. KLEBSIELLA PNEUMONIAE INFECTIONS COMPANY WISE PIPELINE DETAILS

ABAC Therapeutics SA Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Abgentis Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
AmpliPhi Biosciences Corp Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Appili Therapeutics Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Armata Pharmaceuticals Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biomx Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
C3J Therapeutics Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
ContraFect Corp Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Daiichi Sankyo Co Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Debiopharm International SA Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
EnBiotix Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Evaxion Biotech ApS Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
F. Hoffmann-La Roche Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fedora Pharmaceuticals Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Forge Therapeutics Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Kyorin Pharmaceutical Co Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
LegoChem Biosciences Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Melinta Therapeutics Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Microbiotix Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Neoculi Pty Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Nosopharm SAS Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Oryn Therapeutics Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Phico Therapeutics Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shionogi & Co Ltd Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Soligenix Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Spero Therapeutics Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Syntiron LLC Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tetraphase Pharmaceuticals Inc Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxdyn SL Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxxilon AG Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
X4 Pharmaceuticals Klebsiella pneumoniae Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. KLEBSIELLA PNEUMONIAE INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. KLEBSIELLA PNEUMONIAE INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts